• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TFE3 重排性肾细胞癌病例报告:氟代脱氧葡萄糖正电子发射断层显像摄取情况可能有助于诊断。

Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis.

作者信息

Murakami Sho, Nagawa Keita, Inui Takanori, Yamamoto Aya, Suzuki Mizuka, Koga Fumitaka, Motoi Toru, Takaki Yasunobu

机构信息

Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

出版信息

J Kidney Cancer VHL. 2023 Sep 27;10(3):61-68. doi: 10.15586/jkcvhl.v10i3.266. eCollection 2023.

DOI:10.15586/jkcvhl.v10i3.266
PMID:37789903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10542702/
Abstract

Translocation and transcription factor E3 (TFE3)-rearranged renal cell carcinoma (RCC) is a rare subtype of RCCs characterised by the fusion of the TFE3 transcription factor genes on chromosome Xp11.2 with one of the multiple genes. TFE3-rearranged RCC occurs mainly in children and adolescents, although middle-aged cases are also observed. As computed tomography (CT)/magnetic resonance imaging (MRI) findings of TFE3-rearranged RCC overlap with those of other RCCs, differential diagnosis is often challenging. In the present case reports, we highlighted the features of the fluorine-18-labelled fluorodeoxyglucose positron emission tomography with CT (FDG PET-CT) in TFE3-rearranged RCCs. Due to the rarity of the disease, FDG PET-CT features of TFE3-rearranged RCC have not yet been reported. In our cases, FDG PET-CT showed high standardised uptake values (SUVmax) of 7.14 and 6.25 for primary tumours. This might imply that TFE3-rearranged RCC has high malignant potential. This is conceivable when the molecular background of the disease is considered in terms of glucose metabolism. Our cases suggest that a high SUVmax of the primary tumour is a clinical characteristic of TFE3-rearranged RCCs.

摘要

易位性及转录因子E3(TFE3)重排的肾细胞癌(RCC)是肾细胞癌的一种罕见亚型,其特征为Xp11.2染色体上的TFE3转录因子基因与多个基因之一发生融合。TFE3重排的RCC主要发生于儿童和青少年,不过中年病例也有报道。由于TFE3重排的RCC的计算机断层扫描(CT)/磁共振成像(MRI)表现与其他RCC的表现重叠,鉴别诊断往往具有挑战性。在本病例报告中,我们着重介绍了氟-18标记的氟脱氧葡萄糖正电子发射断层扫描联合CT(FDG PET-CT)在TFE3重排的RCC中的特征。由于该疾病罕见,TFE3重排的RCC的FDG PET-CT特征尚未见报道。在我们的病例中,FDG PET-CT显示原发肿瘤的标准化摄取值(SUVmax)分别为7.14和6.25,较高。这可能意味着TFE3重排的RCC具有较高的恶性潜能。从葡萄糖代谢角度考虑该疾病的分子背景时,这是可以想象的。我们的病例提示,原发肿瘤的SUVmax较高是TFE3重排的RCC的临床特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0d/10542702/ddafc1f21b4f/JKCVHL-10-061-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0d/10542702/ddafc1f21b4f/JKCVHL-10-061-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0d/10542702/ddafc1f21b4f/JKCVHL-10-061-g003.jpg

相似文献

1
Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis.TFE3 重排性肾细胞癌病例报告:氟代脱氧葡萄糖正电子发射断层显像摄取情况可能有助于诊断。
J Kidney Cancer VHL. 2023 Sep 27;10(3):61-68. doi: 10.15586/jkcvhl.v10i3.266. eCollection 2023.
2
Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report.与肾细胞癌相关的Xp11.2易位/TFE3基因融合的多模态成像:病例报告
Front Med (Lausanne). 2023 Sep 19;10:1266630. doi: 10.3389/fmed.2023.1266630. eCollection 2023.
3
Papillary Renal Cell Carcinoma in Transplanted Kidney and Xp11.2 Translocation/Transcription Factor E3-Rearranged Renal Cell Carcinoma in the Native Kidney: A Case Report.移植肾中的乳头状肾细胞癌与原发性肾中的Xp11.2易位/转录因子E3重排肾细胞癌:1例报告
J Korean Soc Radiol. 2024 Mar;85(2):437-444. doi: 10.3348/jksr.2023.0102. Epub 2024 Mar 26.
4
Xp11.2 Translocation Renal Cell Carcinoma With Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners.伴有重排的Xp11.2易位性肾细胞癌:不同融合伴侣的独特形态学特征及预后
Front Oncol. 2021 Nov 30;11:784993. doi: 10.3389/fonc.2021.784993. eCollection 2021.
5
The incidence of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in Saudi adult patients with renal cancer: a retrospective tissue microarray analysis.沙特成年肾癌患者中与Xp11.2易位/TFE3基因融合相关的肾细胞癌发病率:一项回顾性组织芯片分析
Pol J Pathol. 2018;69(4):376-383. doi: 10.5114/pjp.2018.81697.
6
Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.Xp11.2 易位/TFE3 基因融合相关性成人肾细胞癌的超声造影表现:与透明细胞肾细胞癌和乳头状肾细胞癌的比较。
Cancer Imaging. 2019 Dec 31;20(1):1. doi: 10.1186/s40644-019-0268-7.
7
Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma with a micropapillary pattern: cases report and literature review.具有微乳头模式的Xp11.2易位/TFE3基因融合肾细胞癌:病例报告及文献复习
Am J Transl Res. 2019 Jan 15;11(1):327-339. eCollection 2019.
8
A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma.在TFE3重排的肾细胞癌中,由t(X;9)(p11.23;p13.3)染色体易位产生的一种新型VCP::TFE3基因融合。
Genes Chromosomes Cancer. 2023 Jun;62(6):361-366. doi: 10.1002/gcc.23127. Epub 2023 Feb 13.
9
TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.TFE3融合变异分析确定了Xp11易位性癌症之间特定的临床病理关联。
Am J Surg Pathol. 2016 Jun;40(6):723-37. doi: 10.1097/PAS.0000000000000631.
10
Evaluation of renal cell carcinoma histological subtype and fuhrman grade using F-fluorodeoxyglucose-positron emission tomography/computed tomography.利用 F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描评估肾细胞癌的组织学亚型和 Fuhrman 分级。
Eur Radiol. 2017 Nov;27(11):4866-4873. doi: 10.1007/s00330-017-4875-z. Epub 2017 May 18.

引用本文的文献

1
Role of F-FDG-PET in renal tumors: insights from WHO 2022 classification.F-FDG-PET在肾肿瘤中的作用:来自世界卫生组织2022年分类的见解。
Jpn J Radiol. 2025 Apr 7. doi: 10.1007/s11604-025-01761-1.
2
Approach to Diagnosis of TFE3-rearranged Renal Cell Carcinoma in a Limited Resource Setting: A Case Report.资源有限情况下TFE3重排肾细胞癌的诊断方法:一例报告
J Kidney Cancer VHL. 2024 Aug 24;11(3):40-44. doi: 10.15586/jkcvhl.v11i3.338. eCollection 2024.

本文引用的文献

1
Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas.46 例 Xp11.2 易位/TFE3 基因融合型肾细胞癌的临床病理、治疗和预后研究。
BMC Urol. 2022 Jul 18;22(1):109. doi: 10.1186/s12894-022-01060-1.
2
Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer.头颈部癌症中 c-MET/HGF 信号转导的调控分子机制。
Mol Cancer. 2022 Jan 26;21(1):31. doi: 10.1186/s12943-022-01503-1.
3
Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma.
氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在原发性和复发性肾细胞癌中的临床应用。
Cancer Imaging. 2021 Feb 25;21(1):25. doi: 10.1186/s40644-021-00393-8.
4
Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion in the elderly: case report and literature review.老年Xp11.2易位性肾细胞癌伴TFE3基因融合:病例报告及文献复习
Int Cancer Conf J. 2020 Jul 8;9(4):182-186. doi: 10.1007/s13691-020-00430-6. eCollection 2020 Oct.
5
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge.MiT家族易位性肾细胞癌:从早期描述到当前认知
Cancers (Basel). 2019 Aug 3;11(8):1110. doi: 10.3390/cancers11081110.
6
Renal Tumors of Childhood: Radiologic-Pathologic Correlation Part 2. The 2nd Decade: From the Radiologic Pathology Archives.儿童肾肿瘤:放射学与病理学对照 第2部分。第二个十年:来自放射病理学档案
Radiographics. 2017 Sep-Oct;37(5):1538-1558. doi: 10.1148/rg.2017160189.
7
MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive marker.透明细胞肾细胞癌中MET的表达及拷贝数状态:预后价值及潜在预测标志物
Oncotarget. 2017 Jan 3;8(1):1046-1057. doi: 10.18632/oncotarget.13540.
8
The Place of FDG PET/CT in Renal Cell Carcinoma: Value and Limitations.氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG PET/CT)在肾细胞癌中的地位:价值与局限性
Front Oncol. 2016 Sep 6;6:201. doi: 10.3389/fonc.2016.00201. eCollection 2016.
9
Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies.XP11.2易位/TFE3基因融合性肾细胞癌的临床特征:一项观察性研究的系统评价和荟萃分析
BMC Urol. 2016 Jul 11;16(1):40. doi: 10.1186/s12894-016-0154-6.
10
Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT.使用18F-FDG PET/CT对肾细胞癌进行术前评估。
Clin Nucl Med. 2015 Dec;40(12):936-40. doi: 10.1097/RLU.0000000000000875.